Sign Up to like & get
recommendations!
0
Published in 2017 at "EJNMMI Physics"
DOI: 10.1186/s40658-017-0191-6
Abstract: BackgroundTechnetium-99m-hydrazinonicotinamide-Tyr3-octreotide (99mTc-HYNIC-TOC) is recognized as a promising radiopharmaceutical for diagnosing neuroendocrine tumors (NETs). However, 99mTc-HYNIC-TOC dosimetry has been investigated only for adults. As pediatric radionuclide therapies become increasingly common, similar dosimetric studies for children are…
read more here.
Keywords:
hynic toc;
tyr3 octreotide;
patient specific;
dosimetry ... See more keywords